Cardiovascular Drug Delivery

Cardiovascular diseases are projected to affect populace across the planet. Cardiovascular diseases contain diseases and disorders associated with heart and blood vessels. Numerous drugs are accessible and are under development for treating cardiovascular diseases based on various signs such as arrhythmiamyocardial infarction, and atherosclerosis. The global range of cardiovascular drug has been involved into many sorts of medicine . Some of the most cardiovascular drugs include anti-hypertensive drugs like calcium channel blockers and angiotensin II receptor antagonists, and hypolipidemic drugs.

    Related Conference of Cardiovascular Drug Delivery

    October 02-03, 2023

    20th International Conference on Pharmaceutical Chemistry

    Frankfurt, Germany
    October 12-13, 2023

    26th World Congress on Nursing, Pharmacology and Healthcare

    Budapest, Hungary
    November 09-10, 2023

    11th International Conference on Clinical Trials

    London, UK
    November 10-11, 2023

    3rd World Biosimilars & Biologics Congress

    Berlin, Germany
    November 27-28, 2023

    19th World Congress on Drug Formulation & Drug Delivery

    Bangkok, Thailand
    December 05-06, 2023

    2nd World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    February 01-02, 2024

    37th World Congress on Pharmacology

    Dubai, UAE
    February 22-23, 2024

    34th Annual European Pharma Congress

    Zurich, Switzerland
    April 04-05, 2024

    17th European Biosimilars Congress

    Madrid, Spain
    April 11-12, 2024

    5th Annual Congress on Antibiotics and Bacterial Infections

    Amsterdam, Netherlands
    May 09-10, 2024

    4th Global Summit on Pharmaceutical Research

    Barcelona, Spain
    May 16-17, 2024

    18th World Drug Delivery Summit

    Rome, Italy
    May 30-31, 2024

    9th Pharmaceutical Chemistry Conference

    Paris, France

    Cardiovascular Drug Delivery Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in